title: Effects of zonisamide on neurotransmitter exocytosis associated with ryanodine receptors.
abstract: To clarify the antiepileptic and neuroprotective actions of zonisamide (ZNS), we determined acute effects of ZNS on exocytosis of GABA and glutamate associated with ryanodine-receptor (Ryr) in rat hippocampus using microdialysis. ZNS increased basal GABA release concentration-dependently without affecting basal glutamate release; however, K(+)-evoked glutamate and GABA releases were reduced by ZNS concentration-dependently. Inhibition of Ryr reduced K(+)-evoked GABA and glutamate releases without affecting their basal releases. Ryanodine affected GABA and glutamate releases biphasic concentration-dependently: lower concentration of ryanodine increased both basal and K(+)-evoked releases of GABA and glutamate, whereas higher concentration reduced them. The therapeutically relevant concentration of ZNS inhibited ryanodine-induced GABA and glutamate releases, and abolished the inflection point in concentration-response curve for ryanodine on neurotransmitter exocytosis. These data suggest that ZNS elevates seizure threshold via enhancement of GABAergic transmission during resting stage. ZNS inhibits propagation of epileptic hyperexcitability and Ryr-associated neuronal damage during neuronal hyperexcitable stage. These demonstrations indicate that the indirect inhibition of Ryr activities by ZNS during neuronal hyperexcitability appear to be involved in the mechanisms of action of antiepileptic and neuroprotective actions of ZNS.
authors.affiliation: Department of Neuropsychiatry, Hirosaki University, Hirosaki 036-8562, Japan.
authors.forename: Shukuko
authors.initials: S
authors.lastname: Yoshida
authors.forename: Motohiro
authors.initials: M
authors.lastname: Okada
authors.forename: Gang
authors.initials: G
authors.lastname: Zhu
authors.forename: Sunao
authors.initials: S
authors.lastname: Kaneko
mesh_terms: D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use*; D004058:Diffusion; D005089:Exocytosis / Q000187:drug effects*; D018698:Glutamic Acid / Q000378:metabolism; D007555:Isoxazoles / Q000627:therapeutic use*; D008297:Male; D017551:Microdialysis; D018377:Neurotransmitter Agents / Q000378:metabolism*; D011188:Potassium / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D012433:Ryanodine / Q000494:pharmacology; D019837:Ryanodine Receptor Calcium Release Channel / Q000187:drug effects*; D000078305:Zonisamide; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
chemical_list: D000927:Anticonvulsants; D007555:Isoxazoles; D018377:Neurotransmitter Agents; D019837:Ryanodine Receptor Calcium Release Channel; D012433:Ryanodine; D018698:Glutamic Acid; D000078305:Zonisamide; D005680:gamma-Aminobutyric Acid; D011188:Potassium